Continuous biologic drugs are the rheumatological treatment by choice

Eduardo Najar
Latina Medical News and Public Health Agency

Thanks to the new medical advances and the knowledge of the immune system it is possible to treat with new therapies autoimmune affections

The complexity of the full knowledge of the immunological system has notably affected those conditions which originate from an irregularity in the same thing, which is notably the hallmark of a totally effective treatment and sure for any type of pathologist.

Agreed with the impressive edition of the journal Medicine and Health Public (MSP), doctor Cristina Ramos Romey, allergist and immunologist, empathize with the changes and advances in science and medicine related to the knowledge of the immune system. From this perspective it has been allowed to remarkably increase the new therapies for treating autoimmune diseases.

Thanks to the advances in rheumatology medicine and the use of biological medicines for patients who are satisfied with a chronic diagnosis in some of their articulations and with which he was able to benefit, they can benefit from this type of therapy and can only do so some type of limitation. However, many of the affidavits developed due to the system have not been validated or scientifically proven in the literature. Therefore, medical advances continue with the power to amplify and increase therapies for each of the conditions under which it is part of this system.

Study of microbiome

As evidenced by the medicine in the article, it is important that it is related to the microbiome, then some studies are the cause in the development of some intestinal affections that are manifested by allergy determinations. This is related to the relationship between the immune system and the primary intestinal epithelium. The interaction of this factor with respect to the rheumatology that many patients present to develop an allergic disorder is linked to these factors.

New herramentas

It uses the synthesis of some proteins as indicated by the specialist in the written article, specifically the PP2A interferes with the action of IL-2, an agent that stimulates the development of pathological some of the immune system. Thanks to this new mechanism it is possible that some autoimmune diseases can be treated all over the arthritis that affect a large percentage of individuals in the population.